Prostatic Acid Phosphatase Is Not a Prostate Specific Target

Autor: Eija Jokitalo, Annakaisa Herrala, Pasi P. Hirvikoski, Eeva-Liisa Eskelinen, Pirkko Vihko, Pekka A. Hellström, Anitta E. Pulkka, Riikka S. Wirkkala, Hannu J. Tuominen, César Araujo, Ileana B. Quintero

Publikováno v: Cancer Research. 67:6549-6554

Prostatic acid phosphatase (PAP) is currently evaluated as a target for vaccine immunotherapy of prostate cancer. This is based on the previous knowledge about secretory PAP and its high prostatic expression. We describe a novel PAP spliced variant m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bfc299e8e364a17cb457d492bc7a2f1
https://doi.org/10.1158/0008-5472.can-07-1651

Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.

Autor: Almangush A; Department of Pathology, University of Helsinki, P.O. Box 21, Helsinki, Finland; University of Turku, Institute of Biomedicine, Pathology, P.O. Box 20520, Turku, Finland; Institute of Dentistry, University of Misurata, P.O. Box 2478 Misurata, Libya. Electronic address: alhadi.almangush@helsinki.fi., Ruuskanen M; Department of Otorhinolaryngology-Head and Neck Surgery, Turku University Hospital and University of Turku, P.O. Box 52, 20521 Turku, Finland., Hagström J; Department of Pathology, University of Helsinki, P.O. Box 21, Helsinki, Finland; HusLab, Helsinki University Hospital, P.O. BOX 100, FI-00029 Helsinki, Finland; Research Programs Unit, Translational Cancer Biology, University of Helsinki, FI-00290 Helsinki, Finland., Hirvikoski P; Department of Pathology, Oulu University Hospital, P.O. Box 10, 90029 Oulu, Finland., Tommola S; Department of Pathology, Fimlab Laboratories, PO Box 66, FI-33101 Tampere, Finland., Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, and Cancer Center of Eastern Finland, University of Eastern Finland, P.O. Box 1627, Kuopio, Finland; Imaging Center, Clinical Pathology, Kuopio University Hospital, P.O. Box 100, Kuopio, Finland., Nieminen P; Medical Informatics and Statistics Research Group, University of Oulu, P.O. Box 5000, FI-90014 Oulu, Finland., Mäkitie A; Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, P.O.Box 263, FI-00029 Helsinki, Finland; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden., Leivo I; University of Turku, Institute of Biomedicine, Pathology, P.O. Box 20520, Turku, Finland.

Publikováno v: Human pathology [Hum Pathol] 2018 Nov; Vol. 81, pp. 211-219. Date of Electronic Publication: 2018 Jul 18.

Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.

Autor: Jouhi L; a Department of Otorhinolaryngology-Head and Neck Surgery , University of Helsinki, Helsinki University Hospital , Helsinki , Finland., Halme E; b Department of Otorhinolaryngology-Head and Neck Surgery , Tampere University Hospital, University of Tampere , Tampere , Finland., Irjala H; c Department of Otorhinolaryngology-Head and Neck Surgery , Turku University Hospital, University of Turku , Turku , Finland., Saarilahti K; d Department of Oncology , Helsinki University Hospital, University of Helsinki , Helsinki , Finland., Koivunen P; e Department of Otorhinolaryngology-Head and Neck Surgery , Oulu University Hospital, University of Oulu , Oulu , Finland., Pukkila M; f Department of Otorhinolaryngology-Head and Neck Surgery , Kuopio University Hospital, University of Eastern Finland , Kuopio , Finland., Hagström J; g Department of Pathology , University of Helsinki, HUSLAB, Helsinki University Hospital , Helsinki , Finland.; i Research Programs Unit, Translational Cancer Biology , University of Helsinki , Helsinki , Finland., Haglund C; h Department of Surgery , University of Helsinki, Helsinki University Hospital , Helsinki , Finland.; i Research Programs Unit, Translational Cancer Biology , University of Helsinki , Helsinki , Finland., Lindholm P; j Department of Oncology , Turku University Hospital, University of Turku , Turku , Finland., Hirvikoski P; k Department of Pathology , Oulu University Hospital, University of Oulu , Oulu , Finland., Vaittinen S; l Department of Pathology , Turku University Hospital, University of Turku , Turku , Finland., Ellonen A; c Department of Otorhinolaryngology-Head and Neck Surgery , Turku University Hospital, University of Turku , Turku , Finland., Tikanto J; e Department of Otorhinolaryngology-Head and Neck Surgery , Oulu University Hospital, University of Oulu , Oulu , Finland., Blomster H; f Department of Otorhinolaryngology-Head and Neck Surgery , Kuopio University Hospital, University of Eastern Finland , Kuopio , Finland., Laranne J; b Department of Otorhinolaryngology-Head and Neck Surgery , Tampere University Hospital, University of Tampere , Tampere , Finland., Grénman R; c Department of Otorhinolaryngology-Head and Neck Surgery , Turku University Hospital, University of Turku , Turku , Finland., Mäkitie A; a Department of Otorhinolaryngology-Head and Neck Surgery , University of Helsinki, Helsinki University Hospital , Helsinki , Finland., Atula T; a Department of Otorhinolaryngology-Head and Neck Surgery , University of Helsinki, Helsinki University Hospital , Helsinki , Finland.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2018 Apr; Vol. 57 (4), pp. 541-551. Date of Electronic Publication: 2017 Nov 17.

Identification of androgen-regulated genes in human prostate.

Autor: Vaarala MH; Department of Surgery, Oulu University Hospital, and Department of Pathology, University of Oulu, FIN-90029 Oulu, Finland. markku.vaarala@oulu.fi, Hirvikoski P, Kauppila S, Paavonen TK

Publikováno v: Molecular medicine reports [Mol Med Rep] 2012 Sep; Vol. 6 (3), pp. 466-72. Date of Electronic Publication: 2012 Jun 19.

HuR expression is a marker of poor prognosis in renal cell carcinoma.

Autor: Ronkainen H; Department of Surgery, Oulu University Hospital, PO Box 21, 90029 OYS, Oulu, Finland., Vaarala MH, Hirvikoski P, Ristimäki A

Publikováno v: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2011 Jun; Vol. 32 (3), pp. 481-7. Date of Electronic Publication: 2010 Dec 16.